Lighter Cars of the Future; How Magnesium Plays a Role in Weight Reduction and Fuel Efficiency


POINT ROBERTS - January 12, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on developments in the auto industry showcased at the North American International Auto Show in Detroit and how magnesium will play a key role in future innovation. The advancement of lighter weight automobiles will result in significant fuel efficiency. The Cadillac ATS by General Motors and the Porsche 911 Carrera and Carrera S Coupes were a few of the high profile cars on display utilizing magnesium.

Ford F-150, one of the best selling vehicles in the country, also announced that its next generation of Ford F-Series will employ aluminum and magnesium for weight savings, a necessary step to meet the looming EPA's CAFÉ standards.
According to Alex Markin, Managing Director of International Magnesium Group "IMG", wholly owned subsidiary of China Direct Industries Inc, (NASDAQ:CDII), "We anticipate the demand for magnesium in the automotive industry to escalate worldwide. This will be driven by mandates to lower fuel consumption and by buyers wanting lighter cars as energy costs continue to increase. Our magnesium segment is positioned to capitalize on the potential growth of magnesium in the automotive industry worldwide through our manufacturing competiveness and policy of stabilized pricing. IMG will be able to provide U.S. automakers with competitively priced magnesium If and when the U.S. government lifts its constraints on imported magnesium,"
Magnesium is stronger and lighter than steel and aluminum; 33% lighter than aluminum, 60% lighter than titanium, and 75% lighter than steel.
According to a press release from Porsche, "Development of the new, seventh-generation 911 Carrera and Carrera S Coupes began with a new aluminum-steel body; the Cabriolets continue the evolution with the addition of an all-new, unique top that retains the characteristic 911 coupe roof line. The intelligent lightweight design makes use of magnesium for weight reduction, improved performance and lower fuel consumption. As with the new 911 coupe, Porsche has managed to make the new Cabriolet models up to 132 pounds lighter than their predecessors."
The Cadillac ATS, General Motors weighs about 3,400 pounds, incorporating an aluminum hood instead of steel, lightweight magnesium engine mounts and other technologies to make it lighter.
Energy Secretary Steven Chu toured the North American International Auto Show and gave a speech on the future of energy, automotives, transportation and the environment from Detroit Public Television and the Detroit Economic Club Wednesday January 11th.
Secretary Chu reinforced his opinion that investing in innovation will play a key role in keeping U.S. workers and companies competitive
Mr Chu stated that the Department of Energy is looking at ways to decrease body weight and is looking to advance lightweight materials. He noted, "If you take off 10% off the weight of the car you can improve fuel efficiency by 6-8% "
According to Frank Sherosky in a recent article in Torque News, as the auto industry shifts, it needs to think better design and materials for lighter cars, not smaller. He says consumers just don't want lighter to mean smaller. "So , think smart body design here. Think structural design with lighter materials, even a combination of extruded aluminum welded to aluminum panels for greater structural integrity. Moving to aluminum, magnesium and carbon fiber, however, will require a major shift in manufacturing processes at auto plants. This will be as significant as the change from processing IC engines to electrification with lithium-ion batteries."
China Direct Industries, Inc. (NasdaqGM: CDII) is a featured stock on Investorideas.com
Visit the company profile
http://www.investorideas.com/CO/CDII/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclosure/ disclaimer: Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All information published is from public filings, news, SEC filings and or company comments and quotes .China Direct Industries, Inc. (NasdaqGM: CDII) One month online marketing paid for by third party Pearl Group; twelve thousand five hundred, to include CFA Commentary, email distribution with other Investorideas.com partners and network of online media which are also compensated as part of this overall marketing (please read their disclosures)
Contact Investorideas.com
800 665 0411
Dvanzant@investorideas.com

China Direct Industries, Inc. (NasdaqGM:CDII) is a featured stock on Investorideas.com
Visit the company profile

Disclosure/ disclaimer: Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All information published is from public filings , news , SEC filings and or company comments and quotes .China Direct Industries, Inc.(NasdaqGM: CDII ) One month online marketing paid for by third party Pearl Group; twelve thousand five hundred, to include CFA Commentary, email distribution with other Investorideas.com partners and network of online media which are also compensated as part of this overall marketing (please read their disclosures)

Wednesday's TSX Top Traders: (TSX:AAA), (TSX: TLM), (TSX:BBD.B), (TSX:HNU)

January 12, 2012 - Investorideas.com, a leader in sector research for independent investors including mining and energy stocks, reports on top trading stocks on the TSX (http://www.tmx.com) for Wednesday January 11 th. The S&P/TSX Composite Index closed at 12,260.94, down 9.72 (-0.08%). The S&P/TSX Venture Composite Index ended at 1531.12, down 11.11 (-0.72%).
Three of the top four most active stocks traded down for the day.
Most active, Allana Potash Corp. (TSX:AAA), closed down at $ 0.840 , down 0.140 or 14.29% on volume of 10,324,561 shares.

Talisman Energy Inc. (TSX:TLM ) ended at $12.370, down 0.120 or 0.96% on 6,312,676 shares.
Bombardier Inc. (TSX:BBD.B) finished the day at $ 4.230, up 0.070 or 1.68% on 5,891,289 shares.
Horizons Natural Gas ETF (TSX:HNU) closed down at 6.010 , down 0.670 or 10.03% on 5,518,420 shares.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Get Mining and energy stock directories
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including mining and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Wednesday's NASDAQ Most Advanced; EMITF, ACRX, IESC, CCIH

POINT ROBERTS, WA - January 12, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on the four top percentage gainers on the NASDAQ for Wednesday January 11th. The NASDAQ closed up slightly at 2710.76, up 8.26 or 0.31%.

The top percentage gainer, Elbit Imaging Ltd. (NasdaqGS: EMITF), closed at $3.32 , moving up 0.7160 (27.50%). The thinly traded stock traded over 84,000 shares, up from its average volume of just 7819 . The Company reported sale of 47 real estatepProperties for US$1.428 Billion by EPN Group.
AcelRx Pharmaceuticals, Inc. (NasdaqGM: ACRX) had respectable gains of 26.48%, closing up at $2.77, up 0.58. ACRX is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.
Integrated Electrical Services, (NasdaqGM: IESC) closed up at $2.40, up 0.49 (25.65%) on very light trading. Last Friday the Company announced the promotion of Robert Lewey to Senior Vice President and Chief Financial Officer to replace Terry Freeman upon his retirement from the Company, effective January 20 , 2012.
ChinaCache International Holdings (NasdaqGM: CCIH) ended at $6.85, up 1.17 (20.60%) on over 266,000 shares, two and a half times its normal trading volume. The Company announced in late December that it reached an agreement with the Shanxi branch of China Unicom and Shanxi Wentian Technology Co., Ltd , the first online game company in Shanxi province of China, to build Shanxi's largest cloud computing data center to enable facilities including disaster recovery centers, enterprise data centers and Internet data centers.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more . Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com

Biotech Stock Alert; Aethlon Medical (OTC: AEMD) Establishes Sepsis & Inflammation Scientific Advisory Board

SAN DIEGO - January 12, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has established a Sepsis & Inflammation Scientific Advisory Board to provide guidance on the development of new therapeutics, including a device to reduce the incidence of sepsis in combat-injured soldiers being advanced under a contract from the Defense Advanced Research Projects Agency (DARPA). The initial members of the Aethlon Sepsis & Inflammation Scientific Advisory Board are Irshad Chaudry, Ph.D., Charles J. Fisher, Jr., MD and Geert Schmid-Schonbein, Ph.D.
About Dr. Chaudry
Dr. Chaudry is the Editor-in-Chief of the journal SHOCK�, a leading research publication that reviews novel therapeutic advances to address shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Dr. Chaudry received a B.S. as well as a M.S. with honors from Sind University, and a Ph.D. from Monash University, Australia. After his postdoctoral training at Toronto University, Canada, he was appointed Instructor and subsequently an Assistant Professor at the Jewish Hospital and Washington University School of Medicine. He then moved to Yale University as an Associate Professor and subsequently became a Professor. He moved to Michigan State University in 1986 as Professor and Director of Research and in 1996 became the Director of the Center for Surgical Research at Brown University. In 2000, he became the Director of the Center for Surgical Research at the University of Alabama at Birmingham, and the Vice Chairman of the Department of Surgery. He has over 500 publications to his credit and is a recipient of the NIH MERIT award.

About Dr. Fisher
Dr. Fisher, founder & CEO of Margaux Biologics, Inc., is a physician scientist with a distinguished career in both academia and industry spanning over 30 years. Prior to joining industry, Dr. Fisher served as Professor and Head of Critical Care Medicine at The Cleveland Clinic Foundation, and has held professor, division chief and director positions at the University of California at Davis Medical Center, Case Western Reserve University and The Cleveland Clinic Foundation. His research in sepsis, host defense and endothelial dysfunction led to his assisting in the founding of Incyte, and his later recruitment to Eli Lilly & Co, where he led the Xigris (activated Protein C) Global Product Team and successfully registered the first drug approved for the treatment of sepsis. He was recruited to Abbott Laboratories as Vice President for Global Pharmaceutical Development and, among other accomplishments, led the registration of Humira (first fully humanized anti-TNF mab). Other medical firsts include his contributions to the development of, and later approval of, sTNF:fc (Enbrel, 1st soluble anti-TNF tx) and IL-1ra (Kinneret, 1st anti-IL-1 tx). Dr. Fisher has numerous patents and publications to his credit. Prior to founding Margaux Biologics, he was Chief Medical Officer and Executive Vice President of Cardiome Pharma Corp. where he led the team that invented, developed, registered and sold to Merck ($800M) vernakalant, a novel, first in class, multi-ion channel drug for atrial fibrillation (Brinavess).
Additionally, Dr. Fisher is a decorated, multi tour combat veteran, with extensive military experience in special operations. He is a Life Member of the Special Operations Medical Association (SOMA), has served as a member of the Defense Science Research Council and on DARPA panels, including one focused on universal host defense. His unique background of direct patient care, basic and clinical research, on the ground combat experience, and leadership at all levels, has led to an exemplary track record of building teams, delivering results, medical firsts and saving lives.
About Dr. Schmid- Schonbein
Dr. Schmid-Schonbein is Distinguished Professor of Bioengineering, Adjunct Professor in Medicine at the University of California, San Diego (UCSD) and director of the UCSD Microcirculation Laboratory where he and his team are studying organ injury mechanisms, apoptosis in hypertension, and triggers for inflammation in the blood circulation. Dr. Schmid-Schonbein earned his Ph.D. in bioengineering from UCSD in 1976. After a three-year post-doctoral fellowship at Columbia University, he returned to UCSD in 1979 as an assistant professor. Some of Dr. Schmid-Schonbein's early research discoveries involved the behavior of infection-fighting white blood cells. Using engineering techniques, he made the first determination of the force with which white blood cells adhere to the walls of blood vessels as part of the initial process of inflammation. Later, Dr. Schmid-Schonbein concluded that the survival of an acutely ill patient can hinge on the degree to which white blood cells are activated. Recently his group discovered a mechanism that leads to activation of white blood cells, which is due to digestive enzymes and may cause cardiovascular disease. Among his many distinctions, Dr. Schmid-Schonbein is a member of the National Academy of Engineering and a fellow of the American Heart Association. He is a founding fellow of the American Institute for Medical and Biological Engineering, and winner of the Melville Medal from the American Society of Mechanical Engineering.
About Aethlon Medical
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT� System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT� product pipeline includes the Aethlon Hemopurifier� to address infectious disease and cancer; HER2osome� to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT� system including the ability to introduce a targeted breast cancer therapy known as HER2osome�, there is no assurance that FDA will approve the initiation of the company's clinical programs or provide market clearance of the company's products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier� as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page on Investorideas.comDisclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) Investorideas.com is paid by AEMD to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs

Solar Stocks Market Turning Positive Slowly but Surely: CSIQ, GTAT, LDK, TSL, YGE added to 2012 Solar Stocks Portfolio

Point Roberts, South Salem, New York - January 11, 2012 - Investorideas.com renewable energy stocks newswire - Solar stocks columnist J Peter Lynch, shares his solar stocks portfolio for January 2012. He has purchased shares in five solar stocks; CSIQ, GTAT, LDK, TSL and YGE.
Solar stocks with J. Peter Lynch:
http://www.investorideas.com/PL/

"Over the past two weeks most of my indicators (technical) have turned positive and despite all the terrible news in the U.S. economy and in Europe what appears to be happening NOW is a buying opportunity.
There is an old saying that a rising tide lifts ALL boats.
The solar sector has literally been destroyed and NONE of the stocks in our solar stock list have given a strong longer term buy signal – but I have gotten so many e-mails regarding what to buy if an investor wants to "bottom fish" in the solar area.
I took a look at the sector over the past few days and we "bought" (simulated, not actual) the following 5 solar stocks yesterday (1-1-2012) at the close these are the best five stocks, in my opinion, if you want to take a chance and bottom fish in the solar industry sector. But keep in mind this is a trading play and should be classified as higher risk money. An additional positive note - all five of these stocks has given a short term "buy" by trading above its 50 day moving average.
Good Luck traders......"
2012 Solar 5 Portfolio –> 1-10-2012

Stock	Price	# Shares
CSIQ	3.10	1000
GTAT	7.99	1000
LDK	4.68	1000
TSL	7.30	1000
YGE	4.12	1000

Background Notes
Keep in mind that there are two basic types of equity (stock) analysis. Below are a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of a company to identify which stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy a stock or sell a stock.
Technical Analysis - this form of analysis will tell you “when” to buy a stock and when to sell the stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.

Mr. Lynch has worked, for 34 years as a Wall Street security analyst, an independent security analyst and private investor in small emerging technology companies. He has been actively involved in following developments in the renewable energy sector since 1977 and is regarded as an expert in this field. He was the contributing editor for 17 years to the Photovoltaic Insider Report, an early publication in PV that was directed at industrial subscribers, such as major energy companies, utilities and governments around the world. He is currently a private investor and has from time to time been a financial/technology consultant to a number of companies. He can be reached via e-mail at: SOLARJPL@aol.com . Please visit his website for the promotion of solar energy - www.sunseries.net.

Read Solar Stocks Commentary with J Peter Lynch at Investorideas.com
http://www.investorideas.com/PL/

Read Peter's technical solar stock reviews:
http://www.investorideas.com/PL/Solar-Stocks-Review.asp

Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com® or any of the industry sector portals. At the time of publication, writers may hold positions in the stocks or companies mentioned.
Research other solar stocks with the renewable energy stocks directory; a global stock directory featuring over 1300 green stocks. Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 12 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investor Ideas:
Source: www.Investorideas.com

Solar Stocks Continue with Yesterday's Gains; (NasdaqGS: CSIQ), (NYSE: LDK), (NasdaqGS: JASO), (NYSE: TSL)

Point Roberts, WA - January 11, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors reports on solar stocks trading for Wednesday January 11th. Following on the heels of yesterday’s runs, several of the solar stocks have passed their gains from yesterday, trading considerably higher today as the industry says panel prices are stabilizing.
Solar stocks have made significant gains in January, asking the question for investors; have solar stocks bottomed and turning around?

Canadian Solar Inc. (NasdaqGS: CSIQ) has moved up to $3.51, up 0.41 (13.23%) 11:42AM EST on just under 1.5 Million shares.
LDK Solar Co. Inc. (NYSE: LDK) is trading at $5.0, up 0.41 (8.76%) 11:42AM EST on over 2 Million shares.
JA Solar Holdings, Co., Ltd. (NasdaqGS: JASO) is up a whopping (20.14%), trading at 1.73 0.29 at 11:45AM EST on over 5.9 Million shares, well above its average trading volume.
Trina Solar Limited (NYSE: TSL) trading up at $8.40, gaining $1.10 (15.07%) 11:41AM EST on over 3.8 Million shares.
Yingli Green Energy (NYSE: YGE) is giving investors impressive gains in today's trading, currently at $4.75, up 0.63 (15.29%) 11:39AM EST.
Solar stocks research:
Use the renewable energy stocks directory to research 1300 green stocks including solar stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Read Peter's solar stocks column at http://www.investorideas.com/PL/
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411

Biopharmaceutical Stock Omeros (NASDAQ: OMER) Trades up over 30% on News

Point Roberts, WA - January 10, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Omeros Corporation (NASDAQ: OMER). The stock is trading at $5.85, up 1.38 (30.87%) 2:31PM with a high of $5.90 following news it has identified compounds that interact selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, bringing the total number of orphan G protein-coupled receptors (GPCRs) unlocked by Omeros to 23, representing 30 percent of the Class A orphan GPCRs.
The Company went on to report, "To date, the number of orphans unlocked by Omeros for drug development equals half of the total number of GPCRs currently targeted by more than 30 percent of all marketed drugs. There are approximately 120 orphan GPCRs and Omeros expects to unlock a large percentage of them, focusing first on Class A orphan GPCRs."
The stock has a 52-week range of $3.16 -$ 8.41.
About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery� platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

China Stock Alert: China Direct Industries (NASDAQ: CDII) Names Hernan Grant Welch Chief Financial Officer

DEERFIELD BEACH, Fla. - January 10, 2012 (InvestorIdeas.com Newswire) - China Direct Industries, Inc. (the "Company") ( NASDAQ:CDII), a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas and provides cross border corporate advisory services announced today that it has named Hernan Grant Welch to the position of Executive Vice President and Chief Financial Officer. Mr. Welch replaces Mr. Andrew Wang who will remain with the company as a consultant to the accounting and finance department. Mr. Welch joins the senior management team at China Direct Industries after spending the last several months as our Vice President of Finance and SEC Reporting.

Mr. Welch has garnered over 30 years of international finance experience in working for both public companies and major auditing firms. Mr. Welch's recent public company experience includes serving from 2007 to 2009 as Director of SEC Reporting and SOX Compliance for Core-Mark International, a NASDAQ listed international logistics services and distribution company. Prior to his position at Core-Mark, Mr. Welch was the Director of Financial Accounting and SEC reporting from for Longview Fibre Company, a public company engaged in forestry management and operations from 2006 until its privatization in 2007. Mr. Welch acted as Director of Financial Reporting for IOWA Telecom from 2004 to 2006, where he helped manage the financial reporting process for the company's initial public offering on the NYSE. From 2002 to 2004, Mr. Welch was Director of Finance and SEC Reporting for Accuimage Diagnostics, Inc., a medical diagnostic software company serving multinational clients domestically, in Europe and Asia. Mr. Welch assisted in the financial preparation for the sale of Accuimage to Merge Diagnostics which took place in January 2005. From 1999 to 2002, Mr. Welch was Vice President and SEC Reporting Director of Equus Entertainment, Inc., a NASDAQ listed entertainment, gaming and real estate company, serving multinational locations in the Caribbean and Latin America.
Prior to his public company work, from 1996 to 1999, Mr. Welch was a partner with Ernst & Young International where his responsibilities as an audit and consulting partner included the supervision of a staff of financial professionals in Caracas, Venezuela and Miami, Florida . Mr. Welch was a Partner with KPMG, LLP from 1989 to 1996 covering engagements in GAAP compliance and SEC reporting. He began his professional career at Deloitte LLP (formerly Deloitte & Touche), providing international audit, tax and management consulting services in 1980 until 1989 and as a partner at Deloitte, Mr. Welch worked on a number of leveraged buy-out projects including KKR Group.
Mr. Welch is a Certified Public Accountant with a Bachelors of Science degree in Economics and Accounting from Fordham University , a Masters Degree in Business Administration in Finance from New York University 's Stern School of Business and a Juris Doctor from George Washington University.
Commenting on this event, Dr. James Wang , Chairman and CEO of China Direct Industries stated, "We are pleased to welcome Hernan to our senior management team as we look to build China Direct Industries into a truly global organization in 2012 and beyond. Hernan brings a wealth of international financial experience, including work in Asia and South America , to China Direct Industries and also has hands on experience in integrating acquisitions as well as managing financial operations from numerous geographic regions. We are confident his wealth of SEC reporting knowledge will prove to be a valuable asset for our company and the other public companies we service in our Consulting segment. We also thank Andrew Wang for his service and look forward to his continued assistance in helping us build our company for the future."
About China Direct Industries, Inc
China Direct Industries, Inc. (NASDAQ:CDII), is a U.S. based company that sources, produces and distributes industrial commodities in China and the Americas and provides business and financial consulting services. Headquartered in Deerfield Beach, Florida with corporate offices in Shanghai, China Direct Industries' unique infrastructure provides a platform to expand business opportunities globally while effectively and efficiently accessing the U.S. capital markets. For more information about China Direct Industries, please visit http://www.cdii.net.
DISCLOSURE NOTICE:
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, China Direct Industries, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations concerning demand for our magnesium products and economic conditions.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Report on Form 10-K for the fiscal year ended September 30, 2011.
Contact Information:
China Direct Industries, Inc.
Richard Galterio or Lillian Wong
Investor Relations
Phone: 1-877- China -57
Email: richard.galterio@cdii.net
lillian.wong@cdii.net

China Direct Industries, Inc. (NasdaqGM:CDII) is a featured stock on Investorideas.com
Visit the company profile

Disclosure/ disclaimer: Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All information published is from public filings , news , SEC filings and or company comments and quotes .China Direct Industries, Inc.(NasdaqGM: CDII ) One month online marketing paid for by third party Pearl Group; twelve thousand five hundred, to include CFA Commentary, email distribution with other Investorideas.com partners and network of online media which are also compensated as part of this overall marketing (please read their disclosures)

Solar Stocks On the Move; (NasdaqGS: CSIQ), (NYSE: LDK), (NasdaqGS: JASO), (NYSE: TSL)

Point Roberts, WA - January 10, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, releases a trading alert for solar stocks on the move in Tuesday’s trading session. Solar stocks with business in China are taking the lead as percentage gainers in today’s trading.

Canadian Solar Inc. (NasdaqGS: CSIQ) is trading up at $3.14, up 0.25 (8.65%) 1:47PM EST, with a high of $3.17. The Company announced last Thursday, the successful completion and grid-connection of a 10 MW ground mounted solar project, a part of a 50MW solar plant, in Hongsibao, Ningxia, in northwest China at the end of 2011.
LDK Solar Co. Inc. (NYSE: LDK) is trading up at $4.61, up 0.24 (5.49 %) 1:53PM EST.The Company reported news last week that China Development Bank Corporation had recently approved a fifteen-year project loan for two solar power plants with a total capacity of 8 Megawatts ("MW") combined. The solar power plants are located in California and are wholly-owned by LDK Solar. CDB has also approved a fifteen-year buyer's credit to KDC Solar LLC ("KDC") for its two New Jersey solar power plants, Imclone and White Rose, consisting of 14.7 MW of its 300 MW portfolio. Additionally, CDB approved two-year construction financing to EPC contractor, Solar Power Inc. ("SPI"), a company majority owned by LDK Solar, for its undertaking of the New Jersey projects.
JA Solar Holdings, Co., Ltd. (NasdaqGS: JASO) is trading at $1.45, up 0.05 (3.21%) 1:58PM ESTon over 3 Million shares.
Trina Solar Limited (NYSE: TSL) is trading up at $7.38, up 0.30 (4.24%) 2:00PM EST with a high of $7.63. On January 4 th the Company announced the establishment of the Changzhou Trina International School.
The initiative is driven by investment from the Changzhou State-Owned Asset Investment Corporation, Changzhou Trina Solar Energy Co., Ltd., and the Changzhou Foreign Language School. The Changzhou Trina International School is also supported by the Changzhou New District Government and the Changzhou Education Bureau.
The international school will primarily attract children from the expatriate community, as well as students from within Jiangsu Province who have demonstrated outstanding academic achievement. The goal of creating a school of recognized international standards is to meet the city's growing demand for a first-class international education service, and will serve as an important pillar to attract international talents to Changzhou. The private school will provide international curricula for kindergarten, elementary, middle school and high school students, and is expected to open operations in the fall of 2012. The Company will invest an estimated $11.9 million for an approximate 31% equity stake.
Solar stocks research:
Use the renewable energy stocks directory to research 1300 green stocks including solar stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Read Peter's solar stocks column at http://www.investorideas.com/PL/
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411

Energy Stock Alert: GEO FINANCE (OTC: GEFI.PK) IDENTIFIES DRILL TARGETS AND RETAINS OPERATOR FOR NEWEST LEASES IN TEXAS

TORONTO, ONTARIO - January 10, 2012 - Investorideas.com energy stocks newswire - Geo Finance Corporation (Pink: GEFI ) is pleased to announce that the managing partner of the newly acquired Jackson A&D leases, Armurtex Oil Corporation (a private corporation) has retained GGP Exploration Ltd of Shreveport Louisiana to operate the 200 acre field located in Archer and Wichita Counties, Texas.

To see this news as the latest FNM Video Press Release go to: http://youtu.be/POc0mhtArrA
The Jackson A&D lease has 30 existing closed wells and one injection well currently located thereon. As announced on November 9 th, 2012, Geo Finance Corporation entered into an option agreement with Armurtex Oil Corporation whereby Armurtex partnered with GEFI to acquire the property.
The operator has identified the initial wells for rework and has established a budget for the necessary work. All of the wells identified were shut in the late 1990's with production, primarily due to low oil prices.
"Because of today's price of oil, a lot of the wells that were shut in during times of low oil prices are profitable again. We're in an excellent position to take advantage of higher oil prices and current technological improvements we're employing on our current properties and on our acquisitions," commented John Arnold, CEO of Geo Finance Corp.
The 200 acre site permits spacing that will allow additional wells to be drilled subject to receipt of permitting as required, satisfactory geological and engineering reports and subject to economically feasible cost and financing analysis.
About Geo Finance Corporation:
Geo Finance Corporation is a Florida entity established to develop and invest in energy related projects including waste to energy, geothermal collection fields, natural gas and petroleum production. The administrative office is based in Toronto, ON, Canada.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Statements in this document regarding the intentions, the expected timetable for completing any transaction, benefits and synergies of any transaction, future opportunities for the company, expectations regarding the value and benefits of any transaction and any other statements about Geo Finance Corporation's managements' future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Any statements that are not statements of historical fact (including statements containing the words "believes," "plans," "anticipates," "expects," estimates and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including, but not limited to: the ability of the parties to consummate any transaction and satisfy the conditions thereunder; the ability to obtain, the impact of any actions taken by any other party to complicate, delay or prevent any transaction and the ability to produce commercially viable quantities of gas or oil from the Archer Field. Except as required by applicable law, Geo Finance Corporation disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this document.
Source: Geo Finance Corp.
Published at Investorideas.com Newswire Investorideas.com was compensated five hundred dollars to publish this news and distribute it through Investordeas.com Newswire, email and its syndicated partners and blogs. Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release.Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Solar Stock up over 6%; Conversion Devices, Inc. (NasdaqGS: ENER)

Point Roberts, WA - January 9, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, releases a trading alert for solar stock Energy Conversion Devices, Inc. (NasdaqGS: ENER), a provider of lightweight, flexible solar products and systems for the building-integrated and commercial rooftop markets.
The stock is trading at $0.31, up 0.02 (6.90%) 1:36PM EST with a high of $0.34 on over 700,000 shares.
About Energy Conversion Devices

Energy Conversion Devices (ECD) (Nasdaq:ENER) has a renowned 51 year history since its formation in Detroit, Michigan and has been a pioneer in materials science and renewable energy technology development. The company has been awarded over 500 U.S. patents and international counterparts for its achievements. ECD's United Solar wholly owned subsidiary has been a global leader in building-integrated and rooftop photovoltaics for over 25 years. The company manufactures, sells and installs thin-film solar laminates that convert sunlight to clean, renewable energy using proprietary technology. UNI-SOLAR(R) brand products are unique because of their flexibility, light weight, ease of installation, durability, and real-world energy production. ECD's technology portfolio also includes the Ovonic Battery Company, the inventor and worldwide licensor of nickel-metal-hydride battery technology and the developer of proprietary advanced lithium-ion cathode materials, along with other emerging energy storage technologies. ECD's Ovonyx joint venture is the inventor and worldwide licensor of phase change memory (PCM) technology.
Use the renewable energy stocks directory to research 1300 green stocks including solar stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Read Peter's solar stocks column at http://www.investorideas.com/PL/
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/ Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411

Biopharmaceutical Stock to Watch: Idenix Pharmaceuticals (NASDAQ: IDIX) Soars on HCV Development News

Point Roberts, WA - January 9, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) following news of its HCV development pipeline. The stock is trading up at $9.36, up 2.31 (32.77%) 11:12AM EST with a high of $10.39.
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) today announced the advancement of its hepatitis C virus (HCV) development pipeline.
IDX719: NS5A Program

Idenix announced today the initiation of a phase I clinical trial of the Company's NS5A inhibitor, IDX719. The first part of the study will evaluate safety, pharmacokinetics and food effect of IDX719 in 48 healthy volunteers. A subsequent part of the study will evaluate three days of IDX719 treatment in treatment-naïve genotype 1 HCV-infected patients and is expected to begin in the second quarter of 2012. Preclinical studies have shown that IDX719 has potent, pan-genotypic activity in vitro with the potential for once-daily dosing.
IDX19368 and IDX19370: Nucleotide Prodrug Program
Further, the Company has selected two additional nucleotide inhibitors, IDX19368 and IDX19370, as potential clinical candidates. The Company anticipates Investigational New Drug (IND) filings in mid-2012.
"Over the past year, Idenix has made significant progress in both our core nucleotide and NS5A programs," commented Ron Renaud, President and Chief Executive Officer of Idenix. "The preclinical profile of IDX719 is very competitive, and we are leveraging the Company's significant nucleotide chemistry expertise to discover novel nucleotides with promising properties as well as continuing to strengthen our IP position. We are excited about the potential of our novel antiviral compounds in the evolving HCV field in the coming year."
ABOUT IDENIX (NASDAQ: IDIX)
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C infection. For further information about Idenix, please refer to www.idenix.com.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Biotech Stock News Alert: Dendreon (NasdaqGS: DNDN) Continues its Run


Point Roberts, WA - January 6, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Dendreon Corporation (NasdaqGS: DNDN). The stock is on the move again trading through yesterday's highs and is currently trading at $11.99, up 1.37 (12.90%) 1:40PM EST with a day's high of $12.18.
The stock closed up at $10.57, up 2.97 (39.08%) in yesterday�s trading session following news of revenue growth.
The Company announced yesterday revenue for the fourth quarter ended December 31, 2011, with gross product revenue of approximately $82 million, a 25% growth over the third quarter ended September 30, 2011, and approximately 230% growth compared to the fourth quarter ended December 31, 2010.Dendreon also reported full-year gross revenues from PROVENGE� (sipuleucel-T) sales of approximately $228 million.
About Dendreon (NasdaqGS: DNDN)

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon’s first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. http://www.dendreon.com/. 
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Thursday’s NASDAQ Winners: DNDN, ACOM, ZUMZ, OCLR

Dendreon (NASDAQ:DNDN) Soars On News of Revenue Growth

POINT ROBERTS, January 06, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Thursday January 05th. The Nasdaq ended higher by 21.50 (0.81%) closing at 2,669.86.

Dendreon Corporation (NASDAQ:DNDN) moved higher by 3.02 (39.74%) to close at $10.62 after the biotechnology company reported solid revenue growth in its fourth quarter. The company said that it revenue grew 230% year-over-year to about approximately $82 million.
Ancestry.com Inc (NASDAQ:ACOM) climbed 4.60 (20.11%) to end at $27.47 on very unusual volume of 3.37 million – over 4.50X its average volume. The company said that it total paying subscribers stood at 1,703,000 at the end of fourth quarter, beating its own target of 1,685,000 – 1,695,000 subscribers. The company also said that now it projects to see revenue growth in the mid-to-high teens for the FY2012.
Zumiez Inc.(NASDAQ:ZUMZ) was the biggest gainer in the retail sector and added 4.62 (17.55%) to end at $30.95 after the company said that it comparable sales grew 10%for the five-week period ending Dec. 31, ahead of analysts’ estimates of 5.1%. Moreover, the company lifted its earnings outlook to 57-58 cents on revenue of $180-$181 million for its fourth quarter, topping analysts’ estimates of 54 cents on revenue of $176.8 million.

Oclaro, Inc. (NASDAQ:OCLR) jumped 15.65% to close at $3.40 after the company reported better-than-estimated fiscal second quarter preliminary sales. The company generated sales of $86 million, beating analysts’ target of $80.8 million.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas Get 13 of the best stock directories online;
Research biotech, oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source – www.Investorideas.com

TSX Stocks to Watch; Thursday's Trading Leaders: (TSX: STP), (TSX: CMK), (TSX: CLL), (TSX: CNE)

January 6, 2012 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for January 05, 2012. The Standard & Poor's/TSX Composite Index gained 10.93 (0.09%) to close at 12,237.40.

Southern Pacific Resource Corp. (TSX:STP) was the top traded stock on the TSX moving up 0.05 (3.40%) to close at C$1.52 with more than 9.39 million shares trading after the company said that it raised its proved plus probable reserves by thirty percent to 234 million barrels of bitumen.
Coal stock, Cline Mining Corp. (TSX:CMK) added 0.36 (21.05%) to close at C$2.07 on news that the company's subsidiary New Elk Coal Company, got the last regulatory approval required for room and pillar mining in the Blue Seam on January 3, 2012.
Connacher Oil and Gas Limited (TSX: CLL) gained 10.26% to close at $0.860 after falling over 12% in the previous trading session. The stock was under selling pressure Wednesday despite the company issuing a positive statement about its fourth-quarter results.
Canacol Energy Ltd. (TSX:CNE) rose 0.070 (8.97%) to finish at C$0.85, extending its rally since late December after the company said that it has successfully drilled in the Rancho Hermoso field and added that it is well financed to go with its 2012 plan of 14 exploration and 26 development wells.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Get Mining and energy stock directories
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including mining and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Solar Energy Stocks; The China Factor


Point Roberts, WA - January 06, 2012 - (Investorideas.com renewable energy/ green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues a solar investor update on recent Chinese funding and investment in the solar sector.

January 5 th, SPI Solar (OTCBB: SOPW) announced that it has secured construction finance facilities totaling $44 million from China Development Bank ("CDB") to fund construction of solar energy facility ("SEF") projects it is working on jointly with KDC Solar in New Jersey. Separately, LDK Solar ("LDK") secured financing facilities of $20 million for two projects it is developing through Engineering, Construction and Procurement contracts with SPI in California. The LDK finance facilities will be used to fund construction costs of the California SEFs.
The stock closed up January 5 th at $ 0.41, up 0.0090 (2.24%) on the news, on over 129,000 shares.
January 4 th Ascent Solar Technologies, Inc. (NasdaqGM: ASTI ) reported that TFG Radiant Investment Group, Ltd of China will increase its ownership interest in solar panel manufacturer. TFG Radiant acquired approximately 20 percent of the outstanding shares of Ascent in August 2011. The increase will put TFG Radiant's ownership at approximately 41 percent.
The stock closed up at $0.56, up 0.14 (33.33%) on over a million shares of trading on January 4 th following the news.
TFG Radiant will purchase the stake in the Company presently owned by Norsk Hydro Produksjon AS for $4 million, or approximately $0.50 per share. The transaction is expected to close within the next 90 days.
Victor Lee, managing director of TFG Radiant and an Ascent board member, said: "We continue to be very excited about the market potential for Ascent's transformational solar power technology. No other manufacturer can match the combination of power density and flexibility, which we believe will enable TFG Radiant to lead in rooftop and portable power applications in East Asia."
Research more solar stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411

TSX Coal Mining Stock to Watch; Cline Mining (TSX: CMK.TO) Closes up 21%

January 6, 2012 - Investorideas.com, a leader in sector research for independent investors issues an investor alert for TSX coal mining stock, Cline Mining Corporation (TSX: CMK.TO). The stock closed trading Thursday at $2.07, up 0.36 (21.05%) on over 8.8 million shares.

The Company issued news that further to its release of December 30, 2011, New Elk Coal Company, a wholly-owned subsidiary of Cline, received the last regulatory approval required for room and pillar mining in the Blue Seam on January 3, 2012. Regulatory approval had previously been granted for mining the Allen seam. Accordingly, all approvals are now in place for mining in both seams in accordance with the mining plan at the New Elk Coal Mine in Las Animas County, southern Colorado.
"As contemplated in the previous news release, New Elk continues to implement its first phase plan with a view to bringing the New Elk Coal Mine into full commercial production of high quality metallurgical coke making coal at a rate of 3.0 million tons of saleable coal annually during its initial 20-year mine project plan period. The full planned production rate is to be attained during the first half of 2012. Saleable coal production during calendar year 2012 is projected at 2.5 million tons, with production in the years 2013 and annually thereafter at the rate of 3.0 million tons. These projections are subject to any unforeseen, unexpected and unanticipated delays or events, including the receipt of normal ongoing regulatory permits and approvals, which could affect production or alter timelines."
About Cline: Cline Mining Corporation (TSX: CMK.TO)
Cline has metallurgical coal property interests in British Columbia, Canada and in Colorado, U.S.A. with NI 43-101 compliant independent Technical Reports. Cline Mining Corporation is a mine development company focused on the exploration and development of metallurgical steel making coals in Canada and the U.S., iron ore in Madagascar and gold from its Cline Lake Gold Mine Property in northern Ontario, Canada.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Research coal stocks and mining stocks at Investorideas.com with global stock directories
Coal Stocks : http://www.investorideas.com/CSS/Stock_List.asp
Mining Stocks : http://www.investorideas.com/Gold_Stocks/Stocks_List.asp
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including mining, nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Biotech Alert: Dendreon (NasdaqGS: DNDN) Trades Up on Revenue News


Point Roberts, WA - January 5, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Dendreon Corporation (NasdaqGS: DNDN). The stock is trading up at $10.57, up 2.97 (39.08%) 3:20PM with a day's high of$11.74.
The Company today reported revenue for the fourth quarter ended December 31, 2011, reporting gross product revenue of approximately $82 million. This represents approximately 25% growth over the third quarter ended September 30, 2011, and approximately 230% growth compared to the fourth quarter ended December 31, 2010. In addition, Dendreon reported full-year gross revenues from PROVENGE� (sipuleucel-T) sales of approximately $228 million.
About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon’s first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. http://www.dendreon.com/.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

TSX Stocks to Watch; Wednesday's Trading Leaders: (TSX: CLL), (TSX: VRO), (TSX: CRK), (TSX: LUN)

January 5, 2012 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for January 04, 2012. The Standard & Poor's/TSX Composite Index added 18.04 (0.15%) to close at 12,226.47.

Connacher Oil and Gas Limited ( TSX:CLL) was the most active stock on the TSX and ended lower by 0.110 (-12.36%) to close at C$0.78 with more than 18.35 million shares traded, correcting from its previous session's rally over 17%. The company made a statement that it sees strong fourth-quarter results, considering sudden jump in crude and bitumen prices.
Vero Energy Inc (TSX:VRO) shares climbed 0.19 (7.17%) to end at C$2.84, extending its prior session rally on news that the company is looking to divest some of its natural-gas assets to a private oil and gas company valuing C$209 million.
Crocodile Gold Corp (TSX:CRK) added 0.23 (1.41%) to close at C$16.57 as prices of crude oil continued to edged higher on weak dollar and ongoing geopolitical tensions between Iran and the U.S. The stock has climbed over 5% over the past one week.
Lundin Mining Corporation (TSX: LUN) increased 0.24 (5.69%) to end at C$4.46 with volume of 3.90 million shares, compared to its 10-day average volume of 3.47 million shares. The stock was supported increased gold prices. Over the past 4 trading sessions, the stock has moved over 10.67%.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Wednesday's NASDAQ Percentage Winners: LCAV, GNOM, NLST, UNIS

POINT ROBERTS - January 5, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday January 04th. The Nasdaq closed flat at 2,648.36.

LCA-Vision Inc.(NASDAQ:LCAV) was the biggest percentage gainer and surged $1.09 or 35.39% to close at $4.17 after the company said that its volume for laser-vision correction services grew 40% quarter-over-quarter during its fourth quarter. The company’s total volume stood at 14,205 procedures during the period. The company also has scheduled its fourth-quarter results on Feb. 14.
Complete Genomics, Inc.(NASDAQ:GNOM) shares added 61 cents or 21.03% to close at $3.51 without any official news. The stock bounced back from its recent lows. Last week, the stock made a new 52-week low of $2.57 and has recovered over 36.50% since then , trading above its key technical moving averages.
Netlist, Inc.(NASDAQ:NLST) ended higher by 32 cents or 13.01% to close at $2.78, with more than 979K shares traded hands, its highest intraday volume in the past month. The stock is trading very near to its 50-Day Moving Average of $2.80, while above its 200-Day Moving Average of $1.92.
Unilife Corp(NASDAQ:UNIS) moved up 41 cents or 12.65% to close at $3.65, supported by positive ratings from analyst at Jefferies. The brokerage firm rerated the stock to buy and set a price target of $7, still representing a potential gain of 92%.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com